Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,497.33
    -1,057.04 (-2.05%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Company News for Jun 8, 2023

  • Casey's General Stores Inc.’s (CASY) shares tumbled 2.9% after reporting fourth quarter fiscal 2023 adjusted earnings per share of $1.49, missing the Zacks Consensus Estimate of $1.58.

  • Ollie's Bargain Outlet Holdings Inc.’s (OLLI) shares tanked 1.5% after posting first quarter fiscal 2023 adjusted earnings per share of $1.49, in line with the Zacks Consensus Estimate.

  • Shares of United Natural Foods Inc. (UNFI) plunged 14.9% after the company reported third quarter fiscal 2023 adjusted earnings per share of $0.54, well below the Zacks Consensus Estimate of $0.63.

  • Shares of Brown-Forman Corp. (BF.B) surged 4% after the company posted fourth quarter fiscal 2023 revenues of $1,05 billion, beating the Zacks Consensus Estimate of $1 billion.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Brown-Forman Corporation (BF.B) : Free Stock Analysis Report

United Natural Foods, Inc. (UNFI) : Free Stock Analysis Report

ADVERTISEMENT

Casey's General Stores, Inc. (CASY) : Free Stock Analysis Report

Ollie's Bargain Outlet Holdings, Inc. (OLLI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research